Staphylococcus aureus: Difference between revisions
imported>Andrew QC Lee |
imported>Andrew QC Lee |
||
| Line 43: | Line 43: | ||
==References== | ==References== | ||
(1) Paniker and Ananthanarayan. Ananthanarayan and Paniker's Textbook of Microbiology. Ed. C.K Pankier. New Delhi: Orient Longman, 2006. | (1) Paniker and Ananthanarayan. Ananthanarayan and Paniker's Textbook of Microbiology. Ed. C.K Pankier. New Delhi: Orient Longman, 2006. | ||
[Sample reference] [http://ijs.sgmjournals.org/cgi/reprint/50/2/489 Takai, K., Sugai, A., Itoh, T., and Horikoshi, K. "''Palaeococcus ferrophilus'' gen. nov., sp. nov., a barophilic, hyperthermophilic archaeon from a deep-sea hydrothermal vent chimney". ''International Journal of Systematic and Evolutionary Microbiology''. 2000. Volume 50. p. 489-500.] | [Sample reference] [http://ijs.sgmjournals.org/cgi/reprint/50/2/489 Takai, K., Sugai, A., Itoh, T., and Horikoshi, K. "''Palaeococcus ferrophilus'' gen. nov., sp. nov., a barophilic, hyperthermophilic archaeon from a deep-sea hydrothermal vent chimney". ''International Journal of Systematic and Evolutionary Microbiology''. 2000. Volume 50. p. 489-500.] | ||
Revision as of 18:24, 2 April 2008
 Articles that lack this notice, including many Eduzendium ones, welcome your collaboration! |
Classification
Higher order taxa
Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae
Species
Staphylococcus aureus
Description and significance
Staphylococcus aureus is a gram positive spherical cocci that grows in a loose, irregular cluster resembling clusters of grapes. The cluster formation is due to the cell division occuring in three planes, with the daughter cell remaining in close proximity.[1] Staphylococcus aureus may also be found singly, in pairs and in short chains of three or four cells. Long chains never occurs. They are nonmotile and nonsporing.
Describe the appearance, habitat, etc. of the organism, and why it is important enough to have its genome sequenced. Describe how and where it was isolated. Include a picture or two (with sources) if you can find them.
Genome structure
Describe the size and content of the genome. How many chromosomes? Circular or linear? Other interesting features? What is known about its sequence? Does it have any plasmids? Are they important to the organism's lifestyle?
Cell structure and metabolism
Describe any interesting features and/or cell structures; how it gains energy; what important molecules it produces.
Ecology
Describe any interactions with other organisms (included eukaryotes), contributions to the environment, effect on environment, etc.
Pathology
How does this organism cause disease? Human, animal, plant hosts? Virulence factors, as well as patient symptoms.
Application to Biotechnology
Does this organism produce any useful compounds or enzymes? What are they and how are they used?
Current Research
Enter summaries of the most recent research here--at least three required
References
(1) Paniker and Ananthanarayan. Ananthanarayan and Paniker's Textbook of Microbiology. Ed. C.K Pankier. New Delhi: Orient Longman, 2006.
| Staphylococcus aureus | ||||
|---|---|---|---|---|
| Scientific classification | ||||
| ||||
| Species | ||||
|
S. aureus |
Staphylococcus aureus are "potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications."[1] S. aureus is so named because the bacteria form yellow clusters, as opposed to the white clusters of S. albus. The bacteria are Gram-positive.
Methicillin-resistant staphylococcus aureus
Methicillin-resistant staphylococcus aureus (MRSA) is a variety of staphylococcus that is resistant to commonly used antibiotics such as methicillin. MRSA has become an important public health problem.[2][3]
Screening for MRSA
Studies are conflicting whether screening patients upon admittance to the hospital reduces nosocomial MRSA infections. A study of surgical patients was negative[4], while a study was that screened all admissions was positive.[5] In the positive study the patients received "5-day regimen comprising mupirocin calcium, 2% twice daily to the nares, and a chlorhexidine 4% wash or shower every 2 days" while in the negative study, patients who were found to have MRSA received "nasal mupirocin ointment and chlorhexidine body washing" without further details provided.
Eradication of MRSA
Numerous studies have looked at the role of decolonization to stop carriage.[6][7][8][9][10][11][12]
Whole body washing alone does not seem sufficient to reduce carriage.[13] Intranasal mupirocin with chlorhexidine soap body washing does not always suffice.mupirocin (group M) or placebo (group P) applied to the anterior nares for 5 days; both groups used chlorhexidine soap for body washing. Mupirocin alone may not work, especially in long-term care facilities[14] or military recruits[15].
A meta-analysis by the Cochrane Collaboration was inconclusive.[16]
References
- ↑ National Library of Medicine. Staphylococcus aureus. Retrieved on 2008-01-03.
- ↑ Klevens RM, Morrison MA, Nadle J, et al (2007). "Invasive methicillin-resistant Staphylococcus aureus infections in the United States". JAMA 298 (15): 1763–71. DOI:10.1001/jama.298.15.1763. PMID 17940231. Research Blogging.
- ↑ Sack K (2007). Deadly Bacteria Found to Be More Common. Retrieved on 2008-01-03.
- ↑ Harbarth S, Fankhauser C, Schrenzel J, et al (2008). "Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients". JAMA 299 (10): 1149-57. DOI:10.1001/jama.299.10.1149. PMID 18334690. Research Blogging.
- ↑ Robicsek A, Beaumont JL, Paule SM, et al (2008). "Universal Surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals". Ann. Intern. Med. 148 (6): 409-18. PMID 18347349. [e]
- ↑ Watanakunakorn C, Axelson C, Bota B, Stahl C (1995). "Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents". Am J Infect Control 23 (5): 306–9. PMID 8585642. [e]
- ↑ Simor AE, Phillips E, McGeer A, et al (2007). "Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization". Clin. Infect. Dis. 44 (2): 178–85. DOI:10.1086/510392. PMID 17173213. Research Blogging.
- ↑ Rohr U, Mueller C, Wilhelm M, Muhr G, Gatermann S (2003). "Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride". J. Hosp. Infect. 54 (4): 305–9. PMID 12919762. [e]
- ↑ Sandri AM, Dalarosa MG, Ruschel de Alcantara L, da Silva Elias L, Zavascki AP (2006). "Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA". Infect Control Hosp Epidemiol 27 (2): 185–7. DOI:10.1086/500625. PMID 16465636. Research Blogging.
- ↑ Dupeyron C, Campillo B, Bordes M, Faubert E, Richardet JP, Mangeney N (2002). "A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit". J. Hosp. Infect. 52 (4): 281–7. PMID 12473473. [e]
- ↑ Walsh TJ, Standiford HC, Reboli AC, et al (1993). "Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome". Antimicrob. Agents Chemother. 37 (6): 1334–42. PMID 8328783. [e]
- ↑ Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M (2007). "Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients". Infect Control Hosp Epidemiol 28 (10): 1155–61. DOI:10.1086/520102. PMID 17828692. Research Blogging.
- ↑ Wendt C, Schinke S, Württemberger M, Oberdorfer K, Bock-Hensley O, von Baum H (2007). "Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial". Infect Control Hosp Epidemiol 28 (9): 1036–43. DOI:10.1086/519929. PMID 17932823. Research Blogging.
- ↑ Kauffman CA, Terpenning MS, He X, et al (1993). "Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment". Am. J. Med. 94 (4): 371–8. PMID 8475930. [e]
- ↑ Ellis MW, Griffith ME, Dooley DP, et al (2007). "Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial". Antimicrob. Agents Chemother. 51 (10): 3591–8. DOI:10.1128/AAC.01086-06. PMID 17682105. Research Blogging.
- ↑ Loeb M, Main C, Walker-Dilks C, Eady A (2003). "Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization". Cochrane Database Syst Rev (4): CD003340. DOI:10.1002/14651858.CD003340. PMID 14583969. Research Blogging.